But recently, some studies showed that the expression level of CLDN1 was low in luminal-like and claudin-low breast cancers, while the expression level of CLDN1 was high in basal-like, most ER negative, BRCA1, medullary breast cancers [35]. This evidence concerns the gene CLDN1 and breast carcinoma.